Bourgeon Capital Management LLC Sangamo Therapeutics, Inc Transaction History

Bourgeon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	BUY	$5.23 - $7.82 $6,799 - $10,166	1,300 Added 104.0%	2,550 $15,000
Q4 2021 Jan 31, 2022	BUY	$7.29 - $10.97 $9,112 - $13,712	1,250 New	1,250 $9,000
Q2 2019 Jul 18, 2019	SELL	$8.75 - $13.03 $87,937 - $130,951	-10,050 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$7.72 - $12.81 $56,742 - $94,153	-7,350 Reduced 42.24%	10,050 $96,000
Q4 2018 Jan 17, 2019	BUY	$9.51 - $16.6 $54,682 - $95,450	5,750 Added 49.36%	17,400 $200,000
Q3 2018 Oct 25, 2018	BUY	$13.05 - $19.05 $152,032 - $221,932	11,650 New	11,650 $197,000

118

43.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $183M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Bourgeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bourgeon Capital Management LLC with notifications on news.